Human metapneumovirus vaccine
The present disclosure provides antigenic pre-fusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding pre-fusion hMPV F polypeptides, compositions comprising antigenic pre-fusion hMPV F polypeptides, compositions comprising nucleic acid sequences encod...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
12.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides antigenic pre-fusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding pre-fusion hMPV F polypeptides, compositions comprising antigenic pre-fusion hMPV F polypeptides, compositions comprising nucleic acid sequences encoding pre-fusion hMPV F polypeptides, and hMPV vaccines.
本披露提供了抗原性融合前hMPV F多肽、编码融合前hMPV F多肽的核酸序列(例如,RNA序列,例如,mRNA序列)、包含抗原性融合前hMPV F多肽的组合物、包含编码融合前hMPV F多肽的核酸序列的组合物和hMPV疫苗。 |
---|---|
Bibliography: | Application Number: CN202280078895 |